Inventor
KUMARAVEL GNANASAMBANDAM
US66 patents
⚠️ This page may combine multiple inventors who share the name “KUMARAVEL GNANASAMBANDAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN MA INC
20 patentsUS9809577B2Nov 7, 2017
Biaryl inhibitors of Bruton's tyrosine kinase
BIOGEN MA INC12 citations92
US9186367B2Nov 17, 2015
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC15 citations91
US10166250B2Jan 1, 2019
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC9 citations84
US9827258B2Nov 28, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC8 citations84
US9572824B2Feb 21, 2017
Bicyclic aryl sphingosine 1-phosphate analogs
BIOGEN MA INC10 citations84
US10081619B2Sep 25, 2018
Biaryl inhibitors of bruton's tyrosine kinase
BIOGEN MA INC7 citations83
US9790229B2Oct 17, 2017
Bruton's tyrosine kinase inhibitors
BIOGEN MA INC11 citations83
US9550798B2Jan 24, 2017
Compounds that are S1P modulating agents and/or ATX modulating agents
BIOGEN MA INC8 citations83
US10034869B2Jul 31, 2018
S1P modulating agents
BIOGEN MA INC2 citations73
US9850206B2Dec 26, 2017
S1P and/or ATX modulating agents
BIOGEN MA INC4 citations73
US9808449B2Nov 7, 2017
S1P modulating agents
BIOGEN MA INC2 citations73
US9771326B2Sep 26, 2017
S1P and/or ATX modulating agents
BIOGEN MA INC6 citations73
US9499485B2Nov 22, 2016
Compounds that are S1P modulating agents and/or ATX modulating agents
BIOGEN MA INC4 citations73
US10759783B2Sep 1, 2020
Biaryl inhibitors of Bruton'S tyrosine kinase
BIOGEN MA INC3 citations72
US9555050B2Jan 31, 2017
ATX modulating agents
BIOGEN MA INC4 citations72
US9522889B2Dec 20, 2016
ATX modulating agents
BIOGEN MA INC5 citations72
US10246456B2Apr 2, 2019
IRAK4 inhibiting agents
BIOGEN MA INC5 citations70
US11572356B2Feb 7, 2023
Biaryl inhibitors of Bruton's tyrosine kinase
BIOGEN MA INC0 citations62
US10894040B2Jan 19, 2021
S1P modulating agents
BIOGEN MA INC0 citations62
US10577367B2Mar 3, 2020
IRAK4 inhibiting agents
BIOGEN MA INC1 citations59
BIOGEN IDEC INC
6 patentsUS7834014B2Nov 16, 2010
A2a adenosine receptor antagonists
BIOGEN IDEC INC10 citations84
US9249146B2Feb 2, 2016
Bruton'S tyrosine kinase inhibitors
BIOGEN IDEC INC9 citations83
US8349849B2Jan 8, 2013
Heterobicyclic sphingosine 1-phosphate analogs
BIOGEN IDEC INC6 citations73
US7674791B2Mar 9, 2010
Triazolopyrazines and methods of making and using the same
BIOGEN IDEC INC7 citations71
US9181191B2Nov 10, 2015
Heterobicyclic sphingosine 1-phosphate analogs
BIOGEN IDEC INC3 citations62
US7285550B2Oct 23, 2007
Triazolotriazines and pyrazolotriazines and methods of making and using the same
BIOGEN IDEC INC3 citations61
PADLOCK THERAPEUTICS INC
4 patentsUS11198681B2Dec 14, 2021
Heteroaryl inhibitors of PAD4
PADLOCK THERAPEUTICS INC4 citations66
US9963448B2May 8, 2018
Bicyclic inhibitors of PAD4
PADLOCK THERAPEUTICS INC2 citations62
US11026937B2Jun 8, 2021
Heteroaryl inhibitors of PAD4
PADLOCK THERAPEUTICS INC1 citations59
US11897866B2Feb 13, 2024
Heteroaryl inhibitors of PAD4
PADLOCK THERAPEUTICS INC0 citations56
SEPRACOR INC
3 patentsUS6207679B1Mar 27, 2001
Antimicrobial agents uses and compositions related thereto
SEPRACOR INC54 citations92
US6172084B1Jan 9, 2001
Quinoline-indole antimicrobial agents, uses and compositions related thereto
SEPRACOR INC50 citations92
US6103905AAug 15, 2000
Quinoline-indole antimicrobial agents, uses and compositions related thereto
SEPRACOR INC17 citations83
THOMAS JERMAINE
2 patentsBUI MINNA
2 patentsBIOGEN INC
2 patentsMILLENNIUM PHARM INC
2 patentsSUNESIS PHARMACEUTICALS INC
2 patentsCaldwell richard d
2 patentsCHEN WEIRONG
1 patentVERSICOR INC
1 patentSUPERVISORS LOUISIANA STATE UN
1 patentARNDT JOSEPH
1 patentUNIV LOUISIANA STATE
1 patentShowing the top 50 of 66 patents by PatentIndex Score.